340B Program issues and patient access to pharmaceuticals.

Coronavirus response efforts, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Legislative issues associated with patient access to treatment, including the CMMI Most Favored Nation demonstration; and step therapy, including related provisions in S. 464/H.R. 2163, the Safe Step Act.

Medical Supply Chain, including issues related to a new rating system; targeted action to support the diversification of certain supplies; additional funding to the Strategic National Stockpile (SNS) and more diverse stockpile; increasing flexibility for supply chains; enhanced FDA reporting and risk mitigation plans for certain medicines; and improved coordination and expansion of mutual reliance agreements, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2). Medical Supply Chain, including issues related to strengthening trade relationships through negotiations with the United States Trade Representative (USTR) and US partners to develop appropriate sources to help secure the US supply chain, along with coordination with trade partners to maintain free movement of goods. Implementation issues affecting patient access to Medicare covered pharmaceuticals and reimbursement adequacy, Medicare Parts B and D benefit parameters, coverage, and reimbursement requirements; use of step therapy in Medicare and health insurance coverage; including related provisions in H.R. 3, the Lower Drug Costs Now Act, H.R. 19, the Lower Costs, More Cures Act, and S. 464/H.R. 2163, the Safe Step Act; and antibiotic development incentives, including related provisions in H.R. 4172, to encourage the development and use of certain antimicrobial drugs and H.R. 3932, to establish a program to develop antimicrobial innovations.

Coronavirus response efforts, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2).

Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including the Most Favored Nation demonstration.
HCR - Health Issues TRD - Trade (domestic/foreign) MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
DENISE HENRY MORRISEY SHANNON FINLEY SARA FRANKO LUKE HATZIS MARTIN B. GOLD ANN JABLON AARON COHEN CAITLIN CANTER JOSEPH EANNELLO CAITLIN CANTER DENISE HENRY MORRISEY SHANNON FINLEY SARA FRANKO LUKE HATZIS MARTIN B. GOLD ANN JABLON AARON COHEN CAITLIN CANTER